Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. MN BioHistory (TM)
Career
Job Search Post a Job Destination MN
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
 
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
Community Service Ad: American Red Cross, Together, we can save a life
Jobs
 
Events
 

Earn a UW master’s or certificate in medical engineering or pharmaceutical bioengineering.

ORCA Annual Meeting & Social: Sept. 22 - Save the Date! (PDF 86 kb)


BioHistory Moment: FDA requested help in removing a hazardous product, "X-33 Water Repellent," from the market

German chemist Felix Hoffmann synthesized aspirin and heroin

On August 30, 1964, the FDA asked state and local health and safety officials for help in removing "X-33 Water Repellent" from the market. The extremely flammable product had caused three deaths and more than 30 injuries through flash explosions, in many cases while it was being used in home basements to waterproof masonry.

Federal oversight of consumer products such as X-33 and many other items used in the home was transferred to the newly created Consumer Product Safety Commission in 1973. One class of consumer products still regulated by the FDA is radiation-emitting products.

More...

Learn about Seattle's PNDRI Life Sciences Incubator Building

PNDRI Sciences Incubator Building, Seattle, WA. A contemporary-designed building provided with modern research systems. Four floors are specifically laboratory space, one floor is a fully equipped vivarium and one floor is clinical space and management offices.

Learn about biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Minnesota, regionally or nationwide.

More...

(Advertising)


Industry News...

    Free News Release Posting & Archiving Service


  • Allergan resolves investigation of past sales and marketing practices related to BOTOX(R)  Allergan announced a resolution with the U.S. Department of Justice regarding Allergan's past U.S. sales and marketing practices relating to therapeutic uses of BOTOX. Allergan pled guilty to a single misdemeanor "misbranding" charge covering the period 2000 through 2005 and will pay $375 million.
    Allergan, Inc.   September 01, 2010  


  • Merck and Cardiome annoumnce BRINAVESS for infusion approved in the European Union  Merck and Cardiome Pharma Corp. announced that the intravenous (IV) formulation of BRINAVESS™ (vernakalant) has been granted marketing approval in the European Union (EU), Iceland and Norway for the rapid conversion of recent onset atrial fibrillation.
    Merck & Co., Inc.  September 01, 2010  


  • BARDA funds development of new way to treat illness from acute radiation  The HHS Biomedical Advanced Research and Development Authority awarded a $153 million contract to Cellerant Therapeutics of San Carlos, Calif., to continue developing a new way to treat an illness caused by exposure to high levels of ionizing radiation which can damage the body’s cells.
    U.S. Health & Human Services  September 01, 2010  


  • U.S. Court of Appeals upholds validity of Lilly's Evista patents through March of 2014  Eli Lilly and Company announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista are valid in the U.S. through March of 2014.
    Eli Lilly and Company  September 01, 2010  


  • Abbott receives FDA approval for first automated molecular test for assessing Hepatitis B   Abbott announced it has received FDA approval to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction to final results.
    Abbott  September 01, 2010  


More... | Submit News Release | Advertising...

Gilead - Careers for Life

New Job Postings...

Free Job Posting Trial Offer
  • Head of Medical Affairs Operations  Seattle Genetics, Inc. (WA)
  • Molecular & FISH Technologist CellNetix Pathology and Laboratories  (WA)
  • Research Technician I/II Benaroya Research Institute (WA)
  • Postdoctoral Research Associate Benaroya Research Institute (WA)
  • Animal Technician I Benaroya Research Institute (WA)
More... | Job Advertising... | About Job Postings...
Novo Nordisk Banner Ad

New Facilities Available...

  • 890 Embarcadero Road Property -- West Sacramento, CA
  • Icogenex Biotech Incubator -- Seattle, WA
  • Biotech and Life Sciences Incubator -- Seattle, WA
  • University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
  • University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA
More... | Facility Advertising...
UW Surplus

Upcoming Events...

  • 09/12/2010: 2010 Agricultural Biotechnology International Conference
  • 09/13/2010: The Future of Bio-Based Chemicals – Inception to Marketplace
  • 09/13/2010: SEB Food Security and Safety Symposium
  • 09/13/2010: ADAPT 2010
  • 09/13/2010: Biotechnology: Science for Managers
More... | Submit Event | Event Advertising...
EquipNet

Learn About Minnesota's BioHistory

Learn About Minnesota's BioHistory Why is there a life science industry in Minnesota? Is the industry growing? What do other states have?

Through Minnesota BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industry in Minnesota.

More...

BioEvolution Posters

WA BioEvolution 2008 Poster

More More...


August: National Immunization Awareness Month

National Immunization Awareness Month

The goal of National Immunization Awareness Month (NIAM) is to increase awareness about immunizations across the life span, from infants to the elderly.

Immunization is one of the most significant public health achievements of the 20th century. Vaccines have eradicated smallpox, eliminated wild poliovirus in the U.S. and significantly reduced the number of cases of measles, diphtheria, rubella, pertussis and other diseases. But despite these efforts, people in the U.S. still die from these and other vaccine-preventable diseases.

More...


BioFact

(1969) - U.S. government takes steps to ban use of insecticide DDT.


It's a Small World

  Immunofluorescence Staining Immunofluorescence Staining  

Science Quote

"The religion that is afraid of science dishonors God and commits suicide."

-  Ralph Waldo Emerson
 (1803 - 1882)

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2010 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

MinnesotaLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of Minnesota.